Apoptosis resistance and PKC signaling: Distinguishing features of high and low metastatic cells

Neoplasia

Volumn 14, Issue 3, 2012, Pages 249-258

  Hong, Sung Hyeok ^a   Ren, Ling ^a   Mendoza, Arnulfo ^a   Eleswarapu, Ananth ^a,b   Khanna, Chand ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE B; PROTEIN KINASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INTERACTION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HUMAN; HUMAN CELL; LUNG METASTASIS; MOLECULAR CLONING; MOUSE; NICK END LABELING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIDEO MICROSCOPY; WESTERN BLOTTING;

EID: 84859127631     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.111498     Document Type: Article

References (48)

1. Chambers AF, Groom AC, and MacDonald IC (2002). Dissemination andgrowth of cancer cells in metastatic sites. Nat Rev Cancer 2, 563-572
2. Steeg PS (2006). Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12, 895-904
3. Cawthorn TR, Amir E, Broom R, Freedman O, Gianfelice D, Barth D, Wang D, Holen I, Done SJ, and Clemons M (2009). Mechanisms and pathways of bonemetastasis: challenges and pitfalls of performing molecular research on patient samples. Clin Exp Metastasis 26, 935-943
4. Liu S, Sun MZ, Tang JW, Wang Z, Sun C, and Greenaway FT (2008). High-performance liquid chromatography/nano-electrospray ionization tandem massspectrometry, two-dimensional difference in-gel electrophoresis and gene micro- array identification of lymphatic metastasis-associated biomarkers. Rapid Commun Mass Spectrom 22, 3172-3178
5. Mira A, Isella C, Renzulli T, Cantarella D, Martelli ML, and Medico E (2009).The GAB2 signaling scaffold promotes anchorage independence and drives atranscriptional response associated with metastatic progression of breast cancer. Oncogene 28, 4444-4455
6. Morioka K, Tanikawa C, Ochi K, Daigo Y, Katagiri T, Kawano H, Kawaguchi H, Myoui A, Yoshikawa H, Naka N, et al. (2009). Orphan receptor tyrosine kinaseROR2 as a potential therapeutic target for osteosarcoma. Cancer Sci 100, 1227-1233
7. Schaefer KL, Eisenacher M, Braun Y, Brachwitz K, Wai DH, Dirksen U, Lanvers-Kaminsky C, Juergens H, Herrero D, Stegmaier S, et al. (2008).Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemo- therapy. Eur J Cancer 44, 699-709
8. Chambers AF, Naumov GN, Vantyghem SA, and Tuck AB (2000). Molecularbiology of breast cancer metastasis. Clinical implications of experimental studieson metastatic inefficiency. Breast Cancer Res 2, 400-407
9. Gassmann P, Haier J, Schluter K, Domikowsky B, Wendel C, Wiesner U, Kubitza R, Engers R, Schneider SW, Homey B, et al. (2009). CXCR4 regulatesthe early extravasation of metastatic tumor cells in vivo. Neoplasia 11, 651-661
10. Hedley BD, Vaidya KS, Phadke P, MacKenzie L, Dales DW, Postenka CO, MacDonald IC, and Chambers AF (2008). BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation. Clin Exp Metastasis 25, 727-740
11. Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, Herms J, and Winkler F (2010). Real-time imaging reveals the single steps ofbrain metastasis formation. Nat Med 16, 116-122
12. Wong CW, Lee A, Shientag L, Yu J, Dong Y, Kao G, Al-Mehdi AB, Bernhard EJ, and Muschel RJ (2001). Apoptosis: an early event in metastatic inefficiency.Cancer Res 61, 333-338
13. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, and Helman LJ (2004). The membrane-cytoskeletonlinker ezrin is necessary for osteosarcoma metastasis. Nat Med 10, 182-186
14. Mendoza A, Hong SH, Osborne T, Khan MA, Campbell K, Briggs J, Eleswarapu A, Buquo L, Ren L, Hewitt SM, et al. (2010). Modeling metastasis biology and therapy in real time in the mouse lung. J Clin Invest 120, 2979-2988
15. Glinsky GV and Glinsky VV (1996). Apoptosis and metastasis: a superior resis-tance of metastatic cancer cells to programmed cell death. Cancer Lett 101, 43-51
16. McConkey DJ, Greene G, and Pettaway CA (1996). Apoptosis resistanceincreases with metastatic potential in cells of the human LNCaP prostate carcinoma line. Cancer Res 56, 5594-5599
17. Glinsky GV, Glinsky VV, Ivanova AB, and Hueser CJ (1997). Apoptosis and metas-tasis: increased apoptosis resistance of metastatic cancer cells is associated with theprofound deficiency of apoptosis execution mechanisms. Cancer Lett 115, 185-193
18. Khanna C, Prehn J, Yeung C, Caylor J, Tsokos M, and Helman L (2000). Anorthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clin Exp Metastasis 18, 261-271
19. Rhim JS, Putman DL, Arnstein P, Huebner RJ, and McAllister RM (1977).Characterization of human cells transformed in vitro by N -methyl-N′-nitro- N -nitrosoguanidine. Int J Cancer 19, 505-510
20. Tsai YC, Mendoza A, Mariano JM, Zhou M, Kostova Z, Chen B, Veenstra T, Hewitt SM, Helman LJ, Khanna C, et al. (2007). The ubiquitin ligase gp78promotes sarcoma metastasis by targeting KAI1 for degradation. Nat Med 13, 1504-1509
21. Horak CE, Mendoza A, Vega-Valle E, Albaugh M, Graff-Cherry C, McDermott WG, Hua E, Merino MJ, Steinberg SM, Khanna C, et al. (2007). Nm23-H1suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2. Cancer Res 67, 11751-11759
22. Koshkina NV, Khanna C, Mendoza A, Guan H, DeLauter L, and Kleinerman ES (2007). Fas-negative osteosarcoma tumor cells are selected during metastasis to thelungs: the role of the Fas pathway in the metastatic process of osteosarcoma. Mol Cancer Res 5, 991-999
23. Aslakson CJ and Miller FR (1992). Selective events in the metastatic processdefined by analysis of the sequential dissemination of subpopulations of a mousemammary tumor. Cancer Res 52, 1399-1405
24. Lee JH, Horak CE, Khanna C, Meng Z, Yu LR, Veenstra TD, and Steeg PS (2008). Alterations in Gemin5 expression contribute to alternative mRNAsplicing patterns and tumor cell motility. Cancer Res 68, 639-644
25. Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, Croce CM, and Van de Woude GF (1984). Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311, 29-33
26. Taylor JG, Cheuk AT, Tsang PS, Chung JY, Song YK, Desai K, Yu Y, Chen QR, Shah K, Youngblood V, et al. (2009). Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest 119, 3395-3407
27. Rofstad EK, Sundfor K, Lyng H, and Trope CG (2000). Hypoxia-inducedtreatment failure in advanced squamous cell carcinoma of the uterine cervix isprimarily due to hypoxia-induced radiation resistance rather than hypoxia- induced metastasis. Br J Cancer 83, 354-359
28. Xie K and Huang S (2003). Regulation of cancer metastasis by stress pathways. Clin Exp Metastasis 20, 31-43
29. Brideau G, Makinen MJ, Elamaa H, Tu H, Nilsson G, Alitalo K, Pihlajaniemi T, and Heljasvaara R (2007). Endostatin overexpression inhibits lymphangiogenesisand lymph node metastasis in mice. Cancer Res 67, 11528-11535
30. Caruso RA, Bellocco R, Pagano M, Bertoli G, Rigoli L, and Inferrera C (2002).Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod Pathol 15, 831-837
31. Gorelik E, Wiltrout RH, Copeland D, and Herberman RB (1985). Modulationof formation of tumor metastases by peritoneal macrophages elicited by variousagents. Cancer Immunol Immunother 19, 35-42
32. Medina RA and Owen GI (2002). Glucose transporters: expression, regulationand cancer. Biol Res 35, 9-26
33. Jentsch TJ, Stein V, Weinreich F, and Zdebik AA (2002). Molecular structureand physiological function of chloride channels. Physiol Rev 82, 503-568.
34. Mendoza M and Khanna C (2009). Revisiting the seed and soil in cancer metastasis. Int J Biochem Cell Biol 41, 1452-1462
35. Sheng S, Qiao M, and Pardee AB (2009). Metastasis and AKT activation. J Cell Physiol 218, 451-454
36. Elliott BE, Meens JA, SenGupta SK, Louvard D, and Arpin M (2005). The membrane cytoskeletal crosslinker ezrin is required for metastasis of breastcarcinoma cells. Breast Cancer Res 7, R365-R373
37. Fukaya Y, Ishiguro N, Senga T, Ichigotani Y, Sohara Y, Tsutsui M, Shioura T, Iwamoto T, and Hamaguchi M (2005). A role for PI3K-Akt signaling in pulmo-nary metastatic nodule formation of the osteosarcoma cell line, LM8. Oncol Rep 14, 847-852
38. Kim CS, Vasko VV, Kato Y, Kruhlak M, Saji M, Cheng SY, and Ringel MD (2005). AKT activation promotes metastasis in a mouse model of follicularthyroid carcinoma. Endocrinology 146, 4456-4463
39. Krishnan K, Bruce B, Hewitt S, Thomas D, Khanna C, and Helman LJ (2006). Ezrin mediates growth and survival in Ewing's sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway. Clin Exp Metastasis 23, 227-236
40. Musashi M, Ota S, and Shiroshita N (2000). The role of protein kinase Cisoforms in cell proliferation and apoptosis. Int J Hematol 72, 12-19
41. Sullivan RM, Stone M, Marshall JF, Uberall F, and Rotenberg SA (2000).Photo-induced inactivation of protein kinase Cα by dequalinium inhibits motility of murine melanoma cells. Mol Pharmacol 58, 729-737
42. Kim J, Thorne SH, Sun L, Huang B, and Mochly-Rosen D (2011). Sus- tained inhibition of PKCα reduces intravasation and lung seeding duringmammary tumor metastasis in an in vivo mouse model. Oncogene 30, 323-333
43. Khanna C (2008). Novel targets with potential therapeutic applications inosteosarcoma. Curr Oncol Rep 10, 350-358
44. Ren L, Hong SH, Cassavaugh J, Osborne T, Chou AJ, Kim SY, Gorlick R, Hewitt SM, and Khanna C (2009). The actin-cytoskeleton linker protein ezrinis regulated during osteosarcoma metastasis by PKC. Oncogene 28, 792-802
45. Xue C, Wyckoff J, Liang F, Sidani M, Violini S, Tsai KL, Zhang ZY, Sahai E, Condeelis J, and Segall JE (2006). Epidermal growth factor receptor overexpres- sion results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Res 66, 192-197
46. Bruland OS, Hoifodt H, Saeter G, Smeland S, and Fodstad O (2005). Hemato- genous micrometastases in osteosarcoma patients. Clin Cancer Res 11, 4666-4673
47. Bruland OS, Hoifodt H, Hall KS, Smeland S, and Fodstad O (2009). Bonemarrow micrometastases studied by an immunomagnetic isolation procedure in extremity localized non-metastatic osteosarcoma patients. Cancer Treat Res 152, 509-515
48. Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, Hoenorhoff MJ, Liu ZY, Costes SV, Cho EH, Lockett S, et al. (2008). Inhibition of meta-static outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 68, 6241-6250.